Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
Condition: Female Sexual Arousal Disorder Interventions: Drug: Sildenafil; Drug: Placebo Sponsors: Strategic Science & Technologies, LLC; Daré Bioscience, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2021 Category: Research Source Type: clinical trials